Skip to main content
Top
Published in: Journal of Cancer Education 2/2018

01-04-2018 | EDITORIAL

On Writing

Author: Arthur M. Michalek

Published in: Journal of Cancer Education | Issue 2/2018

Login to get access

Excerpt

As Editor-in-Chief of this fine journal, I have read countless manuscripts. Some of these submissions have been extremely interesting while others have been rather pedestrian. Some have described innovative methods while others relied on more conventional approaches. Some have produced innovative findings while others produced replication, which is equally important and essential to our science. Some resulted in publication while others did not. One thing that they all had in common is that they were the result of a labor of love. They were the distillation of countless hours of work in the field and of hours of writing and rewrites. During my five years at the helm of this Journal, I have occasionally, and fleetingly, wondered why we write. …
Literature
1.
go back to reference Leigh-Hunt N, Bagguley D, Bash K, Turner V, Turnbull S, Valtorta N, Caan W (2017 Nov.) An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health 152:157–171CrossRefPubMed Leigh-Hunt N, Bagguley D, Bash K, Turner V, Turnbull S, Valtorta N, Caan W (2017 Nov.) An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public Health 152:157–171CrossRefPubMed
2.
go back to reference Frey EF (1985-1986) The earliest medical texts. Clio Med 20(1–4):79–90PubMed Frey EF (1985-1986) The earliest medical texts. Clio Med 20(1–4):79–90PubMed
Metadata
Title
On Writing
Author
Arthur M. Michalek
Publication date
01-04-2018
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 2/2018
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-018-1336-6

Other articles of this Issue 2/2018

Journal of Cancer Education 2/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine